Search
for
Sort by
Research 181–210 of 1000+
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
- Dermatological medications and local therapeutics
- Correction of involutional skin changes using microfocused ultrasound combined with PRP-therapy
- Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey
- Gene Therapy: Recent Advances and Applications in Dermatology
- Actinic Keratosis: Risk Factors, Clinical, Diagnosis and Therapeutics Aspects. Part I
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- An Uncontrolled Innovative Test of Cryo-Chilled Carbon Dioxide as A Novel Amplification of a Nano-Botanical Multi-Acting Therapy in Advanced Stage Androgenetic Alopecia (Aga)
- Journal for ReAttach Therapy and Developmental Diversities
- Comparison of the Therapeutic Effect of Allogeneic and Xenogeneic Small Extracellular Vesicles in Soft Tissue Repair
- Dermatologic Reactions to Targeted Therapy
- Answer of Regenerative Therapy Not Hair Treatment Patients with Androgenetic Alopecia Approved for Hairmetrix® Technology - Case Report
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- MoS2 Nanoclusters-based biomaterials for disease- impaired wound therapy
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Bioorthogonal Catalytic Microneedles Based on a Cytotoxic PEI Matrix for Synergistic Melanoma Therapy
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Pain in pancreatic cancer: A medical oncologist's view
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment